Memphis-based Key Biologics part of $38M acquisition by Charles River Laboratories By: Memphis Business Journal via Business Journals August 17, 2020 at 11:49 AM EDT Memphis' Key Biologics is part of a $38M acquisition by a Massachusetts-based public company. Read More >>